drugset / Trial / NCT03002428
A Comparison of PF708 and Forteo in Osteoporosis Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the effects of two teriparatide products, PF708 and Forteo, in patients with osteoporosis.
Timeline
- Start
- 2016-12
- Primary completion
- 2018-05
- Completion
- 2018-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teriparatide | Protein / enzyme biologic | 20 ug | Subcutaneous |